Salarius Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.

About SLRX

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need.

CEO

David J. Arthur

CEODavid J. Arthur

Employees

Employees16

Headquarters

Houston, Texas

HeadquartersHouston, Texas

Founded

2014

Founded2014

Employees

Employees16

SLRX Key Statistics

Market cap

5.58M

Market cap5.58M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

127.81K

Average volume127.81K

High today

$2.55

High today$2.55

Low today

$2.43

Low today$2.43

Open price

$2.55

Open price$2.55

Volume

34.35K

Volume34.35K

52 Week high

$13.46

52 Week high$13.46

52 Week low

$1.07

52 Week low$1.07

SLRX Earnings

-$3.25

-$2.17

-$1.08

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 9, Pre-Market

ActualExpected Mar 9, Pre-Market

Salarius Pharmaceuticals

Why Robinhood?

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. Show more

SLRX Key Statistics

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need.